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ABSTRACT
Introduction. Ethylene glycol (EG) and methanol (MET) expo-
sures are rare but can cause significant morbidity and mortality. 
Though frequently treated similarly, EG and MET exposures have 
characteristics that are not well differentiated in the literature. We 
sought to describe the clinical characteristics of EG and MET expo-
sures, confirmed with quantitative serum levels.
Methods. An IRB-approved retrospective review of the University 
of Kansas Health System Poison Control Center database from July 
2005 to July 2015 identified all EG/MET exposures evaluated at 
a health care facility. Initial measurements were EG/MET levels, 
serum pH, serum creatinine, anion gap, serum ethanol level, max 
anion gap, max osmolar gap, therapy performed (hemodialysis, 
fomepizole, ethanol) and death.
Results. The search identified 75 cases, with 59 cases having only 
detectable EG levels and 15 cases having only detectable MET levels. 
The average EG level was 126 mg/dL (range 5 - 834). The average 
detectable methanol level was 78 mg/dL (range 5 - 396). The average 
maximum anion gap of the EG positive group was 20 mEq/L (range 
8 - 35). The average maximum anion gap of the MET positive group 
was 14 mEq/L (range 6 - 34). One death was reported in the EG posi-
tive group, with an initial level of 266 mg/dL.
Conclusions. In this study of EG/MET exposures, EG exposures 
were more common than MET exposures, but they had similar 
demographics, laboratory findings, and interventions. Continued 
studies are warranted to characterize these uncommon exposures 
further. Kans J Med 2018;11(3):67-69.
INTRODUCTION
Ethylene glycol (EG) and methanol (MET) are toxic alcohols 
that consistently account for intentional and unintentional poison-
ings in many countries across the world.1 Ethylene glycol is found 
in many household agents such as antifreeze and deicing solution. 
It is a colorless, odorless, and sweet tasting liquid. Methanol is 
found in household and industrial agents such as windshield washer 
fluid. Both toxic alcohols have been reported in cases of accidental 
ingestion, as well as suicide. Patients that overdose on EG or MET 
accumulate toxic levels of glycolic acid and formate, respectively due 
to metabolism of the parent compound.
Ethylene glycol is first converted into glycolaldehyde by the 
enzyme alcohol dehydrogenase, then rapidly into glycolic acid. The 
conversion of glycolic acid to oxalic acid is slow; therefore, glycolic 
acid can accumulate to toxic levels.2 Toxic effects include convulsions, 
coma, metabolic acidosis, hypocalcemia and renal failure. Symptoms 
can occur within 30 minutes of ingestion due to how quickly EG is 
absorbed by the stomach.3 Treatment of EG overdose is based on 
counteracting the buildup of glycolic acid which is accomplished by 
targeting and inhibiting alcohol dehydrogenase through intravenous 
fomepizole or ethanol. The American Academy of Clinical Toxicol-
ogy (AACT) recommends a minimum treatment threshold of 20 mg/
dL of ethylene glycol.2 Hemodialysis is indicated if severe acidemia or 
end organ injury is present.3  
Methanol is absorbed in the gastrointestinal tract and metabolized 
in the liver to formaldehyde by alcohol dehydrogenase, which in turn 
is converted to formate that can accumulate to toxic levels.3 Toxic 
effects include severe abdominal pain, retinal toxicity, acidosis, con-
vulsions and coma. Severe symptoms of MET poisoning occur hours 
later compared to minutes in EG poisoning. The half-life of MET is 
43 hours, so elective hemodialysis often is necessary to enhance elim-
ination or reduce duration of therapy.4 Treatment of MET overdose 
is based on counteracting the buildup of formate. Similar to treating 
EG exposures, targeting and inhibiting alcohol dehydrogenase is the 
foundation for treating MET exposures and the AACT recommends 
a minimum treatment threshold of 20 mg/dL of methanol.2 Hemo-
dialysis may be required if acidemia or end organ injury is present. 
Once metabolism of EG or MET has taken place, patients will 
present with a high anion gap metabolic acidosis and systemic effects 
based on the toxin.5 Prior to metabolism, an increase osmolar gap 
may be present, but this disappears with evolution of the anion gap 
acidosis. 
Along with clinical history and presentation, these laboratory find-
ings guide the management and treatment of EG and MET overdose. 
Distinguishing the etiology of the overdose can be done by measuring 
serum levels of EG or MET and their breakdown products. However, 
this can take several days, when these life-threatening exposures 
require immediate medical attention.6
The literature on the difference in characteristics between EG and 
MET exposures remains limited. While the accumulation of toxic 
metabolites in each exposure is different, the clinical presentation is 
similar.1 Serum chemistry often reveals a high anion gap metabolic 
acidosis and widened anion and osmolar gap for both exposures.5 
Our study objective was to describe the clinical characteristics of EG 
and MET exposures.
METHODS
An IRB-approved retrospective review of all cases of ethylene 
glycol or methanol exposure greater than a mouthful in humans 
reported to the University of Kansas Health System Poison Control 
Center (PCC) from July 1, 2005 to July 1, 2015 were identified using 
the American Association of Poison Control Centers (AAPCC) 
codes for ethylene glycol and methanol.7 Data were anonymized and 
de-identified prior to analysis. The PCC receives calls from the public 
and health care facilities for the entire state of Kansas. All cases that 
were confirmed as non-exposures, exposure via dermal, and expo-
sures via ocular were excluded as serum levels of EG/MET would 
not be observed with these types of exposures.
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sex, month of exposure, exposed substance (EG, MET or both), 
reason for exposure, admission rate, duration of PCC follow up, 
initial EG/MET levels, serum pH, serum creatinine, anion gap, serum 
ethanol level, max anion gap, max osmolar gap, therapy performed 
(hemodialysis, fomepizole, ethanol) and death.
RESULTS
The search identified 75 cases, with 59 cases (79%) having only 
detectable EG levels and 15 cases (20%) having only detectable MET 
levels. There was one case (1%) with simultaneously positive EG and 
MET levels; a reported methanol exposure found to have an EG level 
of 5 mg/dL and a MET level of 109 mg/dL. The average EG level was 
126 mg/dL (range 5 - 834). The average detectable methanol level 
was 78 mg/dL (range 5 - 396). Table 1 shows the patient demograph-
ics. Table 2 characterizes patients with serum positive EG and serum 
positive MET. One death was reported in the EG positive group, with 
an initial level of 266 mg/dL.
Table 1. Patient demographics. 
EG positive MET positive
Total patients 59 15
Mean age (years) 33 [1.6 - 71] 31 [1.2 - 66]
Sex (Male/Female) 37/22 11/4
Intentional ingestion 50 13
Admitted to hospital 57 13
Table 2. Characteristics of patients with serum positive EG 
and serum positive MET. 
EG positive MET positive
Mean initial pH 7.28 [6.6 - 7.52] 7.31 [7.09 - 7.52]
Mean initial creatinine (mg/dL) 1.24 [0.3 - 4.9] 0.98 [0.62 - 1.9]
Mean Max Anion gap (mEq/L) 20 [8 - 35] 14 [6 - 34]
Mean Max Osmolar gap 
(mOsm/kg)
38 [(-) 10 - 129] 38 [3 - 142]
Fomepizole administered 52 11
Ethanol administered 3 3
Hemodialysis performed 25 3
DISCUSSION
In this study of EG/MET exposures, EG exposures were more 
common than MET exposures, but they had similar demographics, 
laboratory findings and interventions. The initial diagnosis of EG 
or MET poisoning is difficult due to the similar clinical presenta-
tion of these exposures and mental status of patients at the time of 
admission. While measurements of serum levels of EG or MET can 
distinguish these two toxic alcohols, analysis can take several days, 
which is problematic for many emergency departments and hospi-
tals.6 
Both EG and MET are readily accessible, frequently found 
in automotive antifreeze, de-icing solution, windshield wiper 
fluid and other industrial products.8 EG and MET can be utilized 
as a substitute for alcohol or, more frequently, as an intentional 
ingestion in suicide attempts. The majority of cases from our study 
were intentional ingestions.
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The mean maximum anion gap for serum positive ethylene glycol 
patients was greater than serum positive methanol patients. There 
is not a clear explanation for this finding. It is possible in this study 
that the presentation of serum positive ethylene glycol patients was 
delayed, resulting in more time for development of an anion gap. 
Although patients with EG exposure had a more severe anion gap 
than patients with MET exposure, fomepizole was the mainstay 
treatment for both exposures.
EG and MET exposures presented with similar systemic effects 
and similar serum chemistries. Management for both EG and MET 
is based on preventing the buildup of toxic metabolites. Fomepizole 
is the most widely used “antidote” for EG and MET exposures.2 It 
works by inhibiting alcohol dehydrogenase, thus preventing metabo-
lism of both EG and MET. Administered intravenously, fomepizole 
induces its own metabolism, so after the fourth 10 mg/kg dose, the 
dose should increase to 15 mg/kg every 12 hours. Previously, ethanol 
was used to treat these exposures. However, due to difficulty in dosing 
and complications, it has fallen out of favor.9 
In this study, fomepizole was used ten times more than ethanol. 
Hemodialysis is the treatment of choice for EG or MET toxicity for 
which the toxic metabolites have already accumulated and caused 
acidemia or end organ injury.3 Hemodialysis also will remove the 
parent compound.
This study had several limitations. It was a retrospective study 
of previously collected poison center data and key information may 
not have been documented. In addition, there is the possibility of 
reporting bias as not all cases of EG/MET exposures may have been 
reported to the poison center. Finally, the sample size of this study 
was small and as it is the experience of a single poison control center, 
its external validity may be limited.
The standard evaluation for exposures to methanol and ethylene 
glycol is not delineated clearly in the medical literature. Most authors 
recommend evaluation with serum levels in cases of methanol and 
ethylene glycol exposure.10 These serum levels can be important in 
deciding whether to implement potentially expensive treatment, such 
as dialysis. However, patients with EG or MET poisonings are in a 
life-threatening situation that requires early intervention based on 
clinical judgment. Therefore, patients presenting with clinical symp-
toms of either toxic alcohol poisoning should be treated immediately, 
with less emphasis on distinguishing whether the etiology is due to 
EG or MET. Continued studies are warranted to characterize these 
uncommon exposures further.
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